Evidence map›Paper›PMID 35084586›Full record

ArticleCellular and molecular life sciences : CMLS2022

Spire1 and Myosin Vc promote Ca

Anna Holthenrich, Julian Terglane, Johannes Naß, Magdalena Mietkowska, Eugen Kerkhoff, Volker Gerke

Open access · hybridAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. NeutrophilFrontiers in cardiovascular medicine · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Tip-end fusion of a rod-shaped secretory organelle.Cellular and molecular life sciences : CMLS · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Anna HolthenrichInstitute of Medical Biochemistry, Center for Molecular Biology of Inflammation, University of Münster, Von-Esmarch-Str. 56, 48149, Münster, Germany.
Julian Terglane *Institute of Medical Biochemistry, Center for Molecular Biology of Inflammation, University of Münster, Von-Esmarch-Str. 56, 48149, Münster, Germany.
Johannes Naß *Institute of Medical Biochemistry, Center for Molecular Biology of Inflammation, University of Münster, Von-Esmarch-Str. 56, 48149, Münster, Germany.
Magdalena MietkowskaInstitute of Molecular Cell Biology, Zoological Institute, Technical University of Braunschweig, Braunschweig, Germany.
Eugen KerkhoffDepartment of Neurology, Molecular Cell Biology Laboratory, University Hospital Regensburg, Regensburg, Germany.
Volker GerkeInstitute of Medical Biochemistry, Center for Molecular Biology of Inflammation, University of Münster, Von-Esmarch-Str. 56, 48149, Münster, Germany. gerke@uni-muenster.de.ORCID http://orcid.org/0000-0001-7208-8206
University of Münster · DETechnische Universität Braunschweig · DEUniversity Hospital Regensburg · DE

Funding

Deutsche Forschungsgemeinschaft GE514/6-3Deutsche Forschungsgemeinschaft SFB1348/A04
6 · The paper itself

Abstract

Weibel-Palade bodies (WPB) are endothelial cell-specific storage granules that regulate vascular hemostasis by releasing the platelet adhesion receptor von Willebrand factor (VWF) following stimulation. Fusion of WPB with the plasma membrane is accompanied by the formation of actin rings or coats that support the expulsion of large multimeric VWF fibers. However, factor(s) organizing these actin ring structures have remained elusive. We now identify the actin-binding proteins Spire1 and Myosin Vc (MyoVc) as cytosolic factors that associate with WPB and are involved in actin ring formation at WPB-plasma membrane fusion sites. We show that both, Spire1 and MyoVc localize only to mature WPB and that upon Ca

Indexed as

ExocytosisBlotting, WesternCalciumCells, CulturedGreen Fluorescent ProteinsHumansHuman Umbilical Vein Endothelial CellsMicrofilament ProteinsMicroscopy, ConfocalModels, BiologicalMyosin Type VNuclear ProteinsRNA Interferencevon Willebrand FactorWeibel-Palade BodiesCalciumGreen Fluorescent ProteinsMicrofilament ProteinsMYO5C protein, humanMyosin Type VNuclear ProteinsSPIRE1 protein, humanvon Willebrand FactorActin nucleationCalcium signalingEndothelial activationExocytosisWeibel–Palade bodies

Identifiers

PMID35084586
PMCPMC8794916
OpenAlexW4210488453

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.